4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-027105
Director bought 350,000 shares at $9.75 ($3,412,500)
From the SEC's structured data for this filing
Trades in this filing
Kariv Tomer · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-04-30 | Purchase : show line 1 in the form | +84,041 | $9.75 | $819,400 | 468,585 | I |
| 2018-04-30 | Purchase : show line 2 in the form | +172,626 | $9.75 | $1,683,104 | 962,504 | I |
| 2018-04-30 | Purchase : show line 3 in the form | +93,333 | $9.75 | $909,997 | 520,396 | I |
| Open-market purchases · 350,000 sh · avg $9.75 · $3,412,500 | ||||||
Loading xslF345X03/doc4.xml…